Aciphex Sprinkle delayed-release rabeprazole regulatory update

FDA approved 5 and 10 mg Aciphex Sprinkle delayed-release rabeprazole capsules treat gastroesophageal reflux disease (GERD) for up to 12 weeks in children ages 1-11 years. A 20 mg tablet formulation o...